301333.SZ
R&G PharmaStudies Co., Ltd.
SZSE · M 科研服务 · CN
CNY 55.08
−6.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.86x
- PEG TTM
- 38.54x
- Price / book
- 2.69x
- Price / sales
- 6.93x
- Price / cash flow
- 57.91x
Enterprise value
- Enterprise value
- CNY 5.1B
- EV / sales
- 5.67x
- EV / EBITDA
- 28.38x
- EV / EBIT
- 33.43x
- Market cap
- CNY 5.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026